Streptozotocin-induced diabetes caused increase in activity and expression of liver iNOS.[33] NO levels were found to be significantly elevated in diabetic liver tissue at a very early stage in the investigation by Stadler et al.[34] Exenatide’s reported anti-diabetic effect may decrease activity and expression of iNOS in liver tissue. The gene discussed is NOS2; the disease is diabetes mellitus.